Evidence map›Paper›PMID 26195553›Full record

ArticleInfection and immunity2015

The O-Antigen Capsule of Salmonella enterica Serovar Typhimurium Facilitates Serum Resistance and Surface Expression of FliC.

Joanna M Marshall, John S Gunn

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Functional loss ofFrontiers in microbiology · 2025
    Article
  5. Article
  6. Frontiers in cellular and infection microbiology · 2021
    Article
  7. Pathogenic signature of invasive non-typhoidalHuman vaccines & immunotherapeutics · 2020
    Review
  8. Review
  9. Article
  10. Article
  11. Periplasmic depolymerase provides insight into ABC transporter-dependent secretion of bacterial capsular polysaccharides.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Frontiers in microbiology · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Joanna M MarshallDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, The Ohio State University, Columbus, Ohio, USA.
John S GunnDepartment of Microbial Infection and Immunity, Center for Microbial Interface Biology, The Ohio State University, Columbus, Ohio, USA gunn.43@osu.edu.
Interface (United States) · USThe Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Mechanisms of the Development and Maintenance of Salmonella Gallbladder CarriageR01AI116917 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI GUNN, JOHN S, MELANDER, CHRISTIAN COREY · 2015 to 2025
$6.1M
Bile, Biofilms and Salmonella Gallbladder CarriageR01AI066208 · NIAID · OHIO STATE UNIVERSITY · PI GUNN, JOHN S · 2007 to 2011
$1.8M
Chronic infection of the gallbladder by SalmonellaR56AI109002 · NIAID · OHIO STATE UNIVERSITY · PI GUNN, JOHN S · 2014 to 2014
$617k
Interdisciplinary Study of the Microbe-Host InterfaceT32AI065411 · NIAID · OHIO STATE UNIVERSITY · PI SCHLESINGER, LARRY S. · 2007 to 2011
$592k
NCI NIH HHS P30 CA016058NIAID NIH HHS AI066208NIAID NIH HHS AI116917NIAID NIH HHS R01 AI066208NIAID NIH HHS R01 AI116917NIAID NIH HHS R56 AI109002NIAID NIH HHS R56AI109002NIAID NIH HHS T32 AI065411NIAID NIH HHS T32-AI-065411
6 · The paper itself

Abstract

Group IV polysaccharide capsules are common in enteric bacteria and have more recently been described in nontyphoidal Salmonella species. Such capsules are known as O-antigen (O-Ag) capsules, due to their high degree of similarity to the O-Ag of the lipopolysaccharide (LPSO-Ag). Capsular polysaccharides are known virulence factors of many bacterial pathogens, facilitating evasion of immune recognition and systemic dissemination within the host. Previous studies on the O-Ag capsule of salmonellae have focused primarily on its role in bacterial surface attachment and chronic infection; however, the potential effects of the O-Ag capsule on acute pathogenesis have yet to be investigated. While much of the in vivo innate immune resistance of Salmonella enterica serovar Typhimurium is attributed to the high-molecular-weight LPS, we hypothesized that the O-Ag capsule may enhance this resistance by diminishing surface expression of pathogen-associated molecular patterns, such as flagella, and increasing resistance to host immune molecules. To test this hypothesis, O-Ag capsule-deficient mutants were constructed, and the loss of O-Ag capsular surface expression was confirmed through microscopy and immunoblotting. Loss of O-Ag capsule production did not alter bacterial growth or production of LPS. Western blot analysis and confocal microscopy revealed that O-Ag capsule-deficient mutants demonstrate reduced resistance to killing by human serum. Furthermore, O-Ag capsule-deficient mutants produced exclusively phase I flagellin (FliC). Although O-Ag capsule-deficient mutants did not exhibit reduced virulence in a murine model of acute infection, in vitro results indicate that the O-Ag capsule may function to modify the antigenic nature of the bacterial surface, warranting additional investigation of a potential role of the structure in pathogenesis.

Indexed as

Blood Bactericidal ActivityAnimalsBacterial CapsulesBacterial ProteinsFemaleFlagellinHumansMiceMice, Inbred BALB CO AntigensSalmonella InfectionsSalmonella typhimuriumSerumBacterial ProteinsFlagellinO Antigens

Identifiers

PMID26195553
PMCPMC4567616
OpenAlexW1773104009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.